Acute coronary syndrome (ACS) encompasses various medical applications, such as diagnosing and managing heart attacks and unstable angina. Key features of ACS include symptoms such as chest pain, shortness of breath, and nausea. Its uses involve timely medical intervention, including medications, percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG), to restore blood flow to the heart and prevent further complications. Effective ACS management reduces the risk of mortality and ensures better outcomes for patients experiencing acute coronary events.
According to Data Bridge Market Research, the Global Acute Coronary Syndrome Market is expected to reach USD 14,810.38 million by 2029. The market is expected to grow with a CAGR of 5.2% in the forecast period of 2022 to 2029.
“Rising prevalence of chronic diseases boosts the market’s growth”
The rising prevalence of chronic diseases contributes to the growth of the acute coronary syndrome (ACS) market. Chronic conditions such as hypertension, diabetes, and obesity increase the risk of developing ACS, a life-threatening condition characterized by decreased blood flow to the heart. As the number of individuals with these risk factors grows, there is a higher incidence of ACS cases. This drives the demand for ACS treatments and management solutions, propelling market growth in the healthcare industry to address this critical cardiovascular condition effectively.
What restraints the growth of the global acute coronary syndrome market?
“Increasing cost of therapeutic surgery restraints the market’s growth”
The increasing cost of therapeutic surgery acts as a restraint on the acute coronary syndrome (ACS) market's growth. Surgical interventions, such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), are expensive procedures that require advanced medical facilities and specialized healthcare professionals. The high cost of these surgeries may limit access to treatment for some patients and impact healthcare budgets. As a result, the growth of the ACS market may be hindered, particularly in regions with limited financial resources for healthcare expenditures.
Segmentation: Global Acute Coronary Syndrome Market
The global acute coronary syndrome market is segmented on the basis of type, treatment, diagnosis, and end user.
- On the basis of type, the global acute coronary syndrome market is segmented into non-St-elevation myocardial infarction, St-elevation myocardial infarction, and unstable angina.
- On the basis of diagnosis, the global acute coronary syndrome market is segmented into stress test, blood test, imagining, and others.
- On the basis of treatment, the global acute coronary syndrome market is segmented into medication and surgery.
- On the basis of end user, the global acute coronary syndrome market is segmented into hospitals and clinics, diagnostic centers, academic institutes, and others.
Regional Insights: North America dominates the Global Acute Coronary Syndrome Market
North America is dominating the global acute coronary market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. The U.S. dominates the pharmaceutical market due to the strong presence of major industry players offering a wide drug portfolio. Additionally, the region benefits from a well-developed healthcare infrastructure, contributing to its leadership in the pharmaceutical industry.
Germany is dominating due to its comprehensive coverage and flexible range of healthcare services available to the population. This extensive offering ensures that individuals have access to a wide range of medical treatments and services, enhancing the overall quality of healthcare in the country.
China is dominating due to the patient pool, particularly the geriatric population, is experiencing exponential growth. With an aging demographic, the demand for healthcare services and treatments is rising, presenting challenges and opportunities for healthcare systems to meet the evolving needs of the elderly.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-acute-coronary-syndrome-market
Recent Development
- In November 2021, Merck has recently completed the acquisition of Acceleron Pharma Inc., signifying a significant strategic opportunity for the company. This acquisition allows Merck to strengthen its cardiovascular portfolio and pipeline, aligning with its rich history and expertise in cardiovascular disease. The integration of Acceleron's groundbreaking research further supports Merck's business development strategy, reinforcing its commitment to advancing innovative treatments and therapies in the field of cardiovascular medicine.
The Prominent Key Players Operating in the Global Acute Coronary Syndrome Market Include:
- Movianto (U.S.)
- Sharp (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Catalent, Inc (U.S.)
- PCI Pharma Services (U.S.)
- Almac Group (U.K.)
- PAREXEL International Corporation (U.S.)
- Bionical Ltd. (U.K.)
- Alium Medical Limited (U.K.)
- MYODERM (U.K.)
- Clinigen Group plc (U.K.)
- Ancillare, LP (U.S.)
- SIRO Clinpharm (India)
- CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC. (U.S.)
- Biocair (U.K.)
Above are the key players covered in the report, to know about more and exhaustive list of global acute coronary syndrome market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Acute Coronary Syndrome Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
